Goetz v. U.S. Food and Drug Administration ( 2022 )

Case MDL No. 2924 Document 1072 Filed 09/02/22 Page 1 of 2 DIST <0 mee tobeatrueand oS cor py of the document on file W PE . he hia UNITED STATES JUDICIAL PANEL FILEO 6 5] southern District of Florida on s oy__ Patrick Edwards MULTIDISTRICT LITIGATION Sep 2, 2022 an \ Daputy Clerk date_Sep 6, 2022- ANGELA E. NOBLE CLERK U.S. DIST. CT. §.D. OF FLA. - MIAMI IN RE: ZANTAC (RANITIDINE) PRODUCTS LIABILITY LITIGATION MDL No. 2924 (SEE ATTACHED SCHEDULE) CONDITIONAL TRANSFER ORDER (CTO -99) On February 6, 2020, the Panel transferred 12 civil action(s) to the United States District Court for the Southern District of Florida for coordinated or consolidated pretrial proceedings pursuant to 28 U.S.C. § 1407. See 437 F.Supp.3d 1368 (J.P.M.L. 2020). Since that time, 398 additional action(s) have been transferred to the Southern District of Florida. With the consent of that court, all such actions have been assigned to the Honorable Robin L. Rosenberg. It appears that the action(s) on this conditional transfer order involve questions of fact that are common to the actions previously transferred to the Southern District of Florida and assigned to Judge Rosenberg. Pursuant to Rule 7.1 of the Rules of Procedure of the United States Judicial Panel on Multidistrict Litigation, the action(s) on the attached schedule are transferred under 28 U.S.C. § 1407 to the Southern District of Florida for the reasons stated in the order of February 6, 2020, and, with the consent of that court, assigned to the Honorable Robin L. Rosenberg. This order does not become effective until it is filed in the Office of the Clerk of the United States District Court for the Southern District of Florida. The transmittal of this order to said Clerk shall be stayed 7 days from the entry thereof. If any party files a notice of opposition with the Clerk of the Panel within this □□□□□ period, the stay will be continued until further order of the Panel. pending at this time, the. FOR THE PANEL: stay is lifted. Sep 02, 2022 af. “UL chaten ermres MULTIDISTRICT LITIGATION John W. Nichols Clerk of the Panel IN RE: ZANTAC (RANITIDINE) PRODUCTS LIABILITY LITIGATION MDL No. 2924 SCHEDULE CTO−99 − TAG−ALONG ACTIONS DIST DIV. C.A.NO. CASE CAPTION CALIFORNIA NORTHERN CAN 3 22−04730 Hinds, et al. v. ANI Pharmaceuticals, Inc., et al. Opposed 8/29/22 CAN 4 22−04731 Torres, et al. v. ANI Pharmaceuticals, Inc., et al. Opposed 8/29/22 CAN 3 22−04768 Goetz et al v. U.S. Food and Drug Administration DELAWARE DE 1 22−01093 Ard et al v. GlaxoSmithKline, LLC et al DE 1 22−01094 Acevedo et al v. GlaxoSmithKline, LLC et al DE 1 22−01095 Adkins et al. v. GlaxoSmithKline, LLC et al